|

Predicting Esophageal Cancer Borders Using PET-Imaging

RECRUITINGPhase 2Sponsored by University Hospital Heidelberg
Actively Recruiting
PhasePhase 2
SponsorUniversity Hospital Heidelberg
Started2024-03-01
Est. completion2026-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06408116

Summary

The study examines the diagnostic precision of endosonography, mpMRI and PET/CT in defining tumor boundaries and tumor spread before and after neoadjuvant therapy and definitive surgery.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Histologically confirmed adenocarcinoma or squamous cell carcinoma of the esophagus, including AEG I and AEG II tumors in the primary situation
* Planned surgical treatment of esophageal carcinoma
* Possible staging advantage through FAPI PET/CT diagnostics
* Patient information and written consent

  -\> KI 60% or ECOG 0/1 (at least: self-sufficiency)
* Age ≥ 18 years

Exclusion Criteria:

* Previous radiation therapy in the tumor region
* Previous tumor disease with \< 5 years of remission
* Surgical therapy is not functionally or technically possible
* Distant metastasis
* Patient is not capable of giving consent
* Concurrent participation in another clinical trial that could affect the results of this trial or the other trial
* Illnesses that do not allow the person concerned to assess the nature and scope as well as possible consequences of the clinical study
* pregnant or breastfeeding women
* Signs that the person taking part is unlikely to comply with the therapy (e.g. unwillingness to cooperate)

Conditions3

CancerEsophagus Cancer, Stage IEsophagus Cancer, Stage II

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.